# Filing Detail

Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001047469-16-013282
Filing Date
2016-05-19
Accepted
2016-05-18 21:51:50
Documents
9
Period of Report
2016-06-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PREM14A | a2228684zprem14a.htm | PREM14A | 3778112
2 | G649547.JPG | g649547.jpg | GRAPHIC | 11059
3 | G448689.JPG | g448689.jpg | GRAPHIC | 64594
4 | G10180.JPG | g10180.jpg | GRAPHIC | 60473
5 | G635117.JPG | g635117.jpg | GRAPHIC | 118994
6 | G801299.JPG | g801299.jpg | GRAPHIC | 86162
7 | G140729.JPG | g140729.jpg | GRAPHIC | 8121
8 | G142733.JPG | g142733.jpg | GRAPHIC | 2884
9 | G360912.JPG | g360912.jpg | GRAPHIC | 9362
| Complete submission text file | 0001047469-16-013282.txt |  | 4278217

Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-33277 | Film No.: 161661807
SIC: 2834 Pharmaceutical Preparations